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Abstract
Introduction
Despite evidence that breast cancer screening reduces 
morbidity and mortality, many women do not obtain mam-
mograms. Our objective was to analyze the relationship 
between income and mammography screening for mem-
bers enrolled in a large health plan in Hawaii.
Methods
We analyzed claims data for women (N = 46,328) aged 
50 to 70 years during 2003 and 2004. We used parametric 
and nonparametric regression techniques. We used probit 
estimation to conduct multivariate analysis.
Results
At the 5th percentile of the earnings distribution, the 
probability of mammography is 57.1%, and at the 95th 
percentile, it is 67.7%. Movement from the 5th percentile 
to the 35th percentile of the earnings distribution increas-
es the probability of mammography by 0.0378 percentage 
points. A similar movement from the 65th percentile to 
the  95th  percentile  increases  the  probability  by  0.0394 
percentage points. Also, we observed an income gradient 
within narrowly defined geographic regions where physi-
cal access to medical care providers is not an issue.
Conclusion
We observed a steep income gradient in mammography 
screening in Hawaii. Because of the prevalence of measure-
ment error, this gradient is probably far greater than our 
estimate. We cannot plausibly attribute our findings to dis-
parities in coverage because 100% of our sample had health 
insurance coverage. The gradient also does not appear to 
result from poorer people residing in areas that are geo-
graphically isolated from providers of medical care.
Introduction
According to the U.S. Preventive Services Task Force, 
mammography screening is estimated to reduce mortal-
ity  from  breast  cancer  by  20%  to  30%  (1). Despite  this 
reduction in mortality, however, mammography is greatly 
underused by women who are at risk for breast cancer (2-
5). Moreover, the problem of underutilization of mammog-
raphy is exacerbated by low socioeconomic status (SES). 
Studies show that use is low among African Americans 
(6), people with low levels of education (7,8), and people 
with low incomes (7). Policies designed to increase the use 
of preventive medicine among the poor may play a positive 
role in mitigating the gradient or the ubiquitous correla-
tion between SES and health (9,10).
In this study, we investigate the relationship between 
race and income and breast cancer screening in Hawaii. 
The data used are well suited for this investigation for two 
reasons. First, we used claims data from a large health 
plan, not patient self-reports, which tend to overstate mam-
mography use (2). Second, we also used U.S. census income 
data by census tract, whereas other studies have used wide 
income brackets (11) or census data by zip code (3).
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Methods
Sample selection and variable descriptions 
We analyzed claims data from a large health insurance 
plan in Hawaii that provides coverage to approximately half 
of the state’s population. In our study, we included women 
(N = 46,328) aged 50 to 70 years during 2003 and 2004. 
The sample contained variables on breast cancer screen-
ing, age, insurance plan type, morbidity level, income, and 
race. Table 1 provides variable definitions and descriptive 
statistics for our sample. Our outcome of interest was a 
variable that indicates whether women in our sample had 
a mammogram during the years 2003 or 2004.
We used income data from the 2000 U.S. census. For 
each census tract, we computed median income using two 
measures: family income and per capita family income, 
which is family income divided by the number of people 
in the household. We then used global positioning system 
software to determine the census tract of each member in 
our sample and merged the income data by census tract 
into  the  claims  database  using  member  addresses.  Our 
data covered a total of 280 census tracts.
We obtained data on race from a member satisfaction 
questionnaire administered by the health plan each year 
to  a  random  sample  of  its  members.  We  obtained  self-
reported race information for 38% of the study population 
(Table 1). However, because nonresponse may not have 
been  random,  this  38%  probably  does  not  constitute  a 
random sample. To address this issue, we constructed a 
dummy variable indicating whether or not the race data 
were missing.
We used a morbidity index from the Adjusted Clinical 
Group  case-mix  adjustment  system,  which  categorizes 
a  patient’s  clinical  conditions  from  the  International 
Classification of Disease, Ninth Revision into one of six 
integer  categories  ranging  from  zero  through  five  (12). 
Higher numbers indicate worse morbidity. This measure 
of morbidity is a risk-adjustment tool that measures the 
illness burden of patients and their expected consumption 
of health services. We calculated the median value of the 
index for 2003 and 2004 (Table 1).
Breast cancer screening  
To  identify  members  who  had  breast  cancer  screen-
ing,  we  used  the  following  codes  from  the  Health  Plan 
Employer Data and Information Set (HEDIS), which is 
used by more than 90% of America’s health plans to mea-
sure performance on dimensions of care and service (13):
• Primary Diagnosis Code: V76.11, V76.12 or
• Additional Diagnosis Code: V76.11, V76.12 or
• Surgical Procedure Code: 87.36, 87.37
Regression techniques 
We used two regression techniques. First, we estimated 
nonparametric local linear regressions (14), which allowed 
us  to  see  how  the  propensity  to  obtain  mammography 
screening responds to income without imposing any para-
metric assumptions on the data (15). Although nonpara-
metric regression enabled us to investigate the relationship 
between mammography and income as flexibly as possible, 
it was a cumbersome task to conduct a multivariate analy-
sis with nonparametric techniques because of data limita-
tions and what is known in statistics and econometrics as 
the “curse of dimensionality.” Thus, we turned to probit esti-
mation to conduct our multivariate analysis. Multivariate 
probit models allowed us to quantify the impact of SES on 
the probability of mammography screening while control-
ling for confounding factors. We calculated the marginal 
effects for each of the variables in our probit regressions. 
The  marginal  effect  for  the  ith  covariate  is  defined  as 
∂P(y | x) = φ(xβ)βi ∂xi
 
where φ(.) is the probability density function of a standard 
normal random variable, x is the mean of our data vec-
tor, and βi is the coefficient on the ith covariate (16). To 
address concerns about correlations among observations 
within census tracts, we adjusted the SEs of our coefficient 
estimates for clustering within census tracts (15). We used 
Stata (StataCorp LP, College Station, Texas) for all esti-
mation procedures.
Results
Breast cancer screening rates
The overall screening rate for women in our sample was 
64% for the 2-year study period. Figure 1 shows mammog-
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ences in screening rates among age groups.
Regression results
Figure  2  displays  the  results  obtained  by  estimating 
a  local-linear  regression  of  the  mammography  dummy 
on the log of per capita household income. In the figure, 
we predict the probability of mammography for incomes 
ranging from the bottom 5th percentile to the top 95th 
percentile of the earnings distribution. The figure shows a 
wide disparity in the demand for mammography screening 
by income. At the lowest end, the probability of obtaining 
a mammogram is 57.1%, whereas at the highest end, the 
probability is 67.7%.
Table 2 presents the results of probit models. In columns 
1 and 2 of Table 2, we report the correlation between per 
capita family income and the probability of obtaining a 
mammogram  without  any  additional  control  variables 
(column 1) and with a set of age dummies (column 2). Both 
estimates are positive and significant. A 1% increase in per 
capita family income is associated with an increase in the 
probability of obtaining a mammogram of 0.001 percent-
age points. In less infinitesimal terms, calculations based 
on the estimates in column 2 suggest that movement from 
the 5th percentile to the 35th percentile of the earnings 
distribution  increases  the  probability  of  mammography 
by  0.0378  percentage  points.  A  similar  movement  from 
the 65th percentile to the 95th percentile has an effect of 
0.0394 percentage points. As in Figure 1, we do not see any 
substantial variation in mammography screening among 
age groups.
Column 3 is identical to column 2 except that we use fam-
ily income in lieu of per capita family income. We now see 
that the marginal effect of income is cut by roughly 22.5%. 
Presumably, the reason for this decrease is that per capita 
income is a better proxy for the family’s living standards. 
Thus, we expect less attenuation bias when using per capi-
ta family income than when using total family income.
In columns 4 and 5, we control for the member’s morbid-
ity level. Column 4 includes the actual morbidity index, 
and column 5 includes dummy variables for each morbid-
ity level. We see that the higher morbidity levels as mea-
sured are highly correlated with obtaining a mammogram. 
We also see that the inclusion of morbidity controls does 
not alter the estimated effect of income.
In  column  6  of  the  table,  we  include  dummy  vari-
ables indicating the member’s location. The locations are 
east Hawaii, west Hawaii, Kauai, Lanai, Maui, Molokai, 
Honolulu, and Oahu other than Honolulu. We see that 
inclusion of these dummies increases the effect of income 
by 28.6%. The inclusion of regional dummies identifies the 
relationship  between  changes  in  income  and  mammog-
raphy screening within regions of Hawaii. Moreover, the 
higher coefficient on income associated with the regional 
dummies  suggests  a  relationship  between  income  and 
mammography screening within regions of Hawaii.
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Figure 1. Breast cancer screening rates by age group, Hawaii, 200–2004.
Figure 2. Probability of obtaining a mammogram among a sample of 
women aged 50 to 70 years, for incomes ranging from the 5th percentile to 
the 95th percentile of the earnings distribution, Hawaii, 200–2004.VOLUME 4: NO. 4
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In  column  7,  we  add  a  dummy  variable  indicating 
whether or not the individual is a member of a health 
maintenance  organization  (HMO).  The  HMO  dummy 
is  positive  and  significant.  While  holding  other  factors 
constant, we see that belonging to an HMO increases the 
probability of mammography screening by 0.016, which 
constitutes  a  2.5%  increase  in  the  mean  probability  of 
obtaining a mammogram.
Column 7 also includes a set of race dummies. We see 
some  variation  across  race.  Mammography  screening  is 
most common among Chinese women, who are followed by 
Japanese women. The dummy variable indicating missing 
race data is negative and significant, suggesting that race 
data are not missing randomly.
Table 3 provides more details for column 5 of Table 2. 
We  show  results  only  for  east  Hawaii,  Maui,  Honolulu,   
and  parts  of  Oahu  other  than  Honolulu  because  other 
regions of the state yielded samples that were too small. 
Although  some  regions  such  as  east  Hawaii  and  Maui 
have reasonable sample sizes, they lack a large number 
of census tracts, which tend to be concentrated on Oahu. 
Accordingly, we may still expect imprecise estimates for 
these regions. Table 3 shows that even within narrowly 
defined geographic regions, the demand for mammography 
by income varies, consistent with column 6 of Table 2.
Discussion
Main findings
The overall screening rate of 64% in our sample is broad-
ly consistent with other estimates of mammography (2,3). 
It  is  important  to  emphasize,  however,  that  estimates 
using self-reported data tend to be higher than estimates 
using insurance or hospital records (2,4).
We document a large disparity in mammography use 
across  the  earnings  distribution  in  Hawaii.  At  the  5th 
percentile of the earnings distribution, the probability of 
mammography is 57.1%, and at the 95th percentile, it is 
67.7%. We find that a 1% increase in income increases 
the  probability  of  having  a  mammogram  by  0.001.  We 
emphasize  that  our  measures  of  family  income  contain 
error because they measure only median income in a given 
census tract. Given the conventional wisdom that classi-
cal measurement error will tend to attenuate coefficient 
estimates, it is reasonable to expect that the true relation-
ship between income and mammography screening is far 
greater than we have estimated (17). In other words, the 
real problem is probably far worse than we document.
We  estimate  a  stronger  relationship  between  income 
and mammography screening than other studies that use 
multivariate probit analysis (3,11). There are two reasons 
for the stronger relationship. First, we merged in income 
by census tract, whereas other studies have used income 
by zip code (which is coarser) or have used wide income 
brackets. The second reason for the stronger relationship 
is that we used income per household member. For both of 
these reasons, we have a more precise measure of family 
income, which mitigates the attenuation bias that results 
from less well-measured income.
The large disparity in mammography across the earn-
ings distribution observed in our study is interesting for 
two reasons. First, despite having 100% coverage of mam-
mography in our sample, we still see a higher demand for 
preventive medical care among the rich than among the 
poor. Income plays a large role in a population where every-
body has health insurance and there are no out-of-pocket 
expenses  for  obtaining  mammograms.  While  universal 
health  coverage  may  mitigate  socioeconomic  disparities 
in the demand for preventive medicine, as suggested by 
the Rand Health Insurance Experiment (18), our findings 
suggest that universal health coverage will not eliminate 
disparities. Rather, our findings suggest that a gradient in 
the consumption of prophylactic health care would persist 
even with universal coverage. Second, we saw that the 
income gradient exists within narrowly defined geographic 
regions  such  as  the  County  of  Honolulu,  where  physi-
cal access to medical care providers is not an issue. The 
observed socioeconomic gradient in the demand for mam-
mography screening does not appear to be the consequence 
of poorer people residing in areas that are geographically 
isolated from providers of medical care.
We  also  determined  that  higher  morbidity  levels  are 
highly  correlated  with  obtaining  a  mammogram.  To 
understand the positive coefficient on the morbidity index 
in Table 2, it is important to note that many measures of 
morbidity tend to be highly correlated with the patient’s 
use of medical services or medical demand (19). Moreover, 
many studies have also shown that physician recommen-
dation, which is more likely to occur when use of medical 
services is high, is a strong predictor of mammography 
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ing that the morbidity index is such a strong predictor of 
mammography screening.
The effect of income was not altered by the inclusion of 
morbidity controls in Table 2, which is curious, given that 
a strong correlation between income and health has been 
documented in virtually every context imaginable (9,10). 
This result is less surprising, however, when one considers 
that our morbidity index is probably measuring medical 
demand, at least to some extent, and that medical demand 
is a function of both income and health status. Each func-
tion tends to affect the demand for medical care in oppos-
ing ways. On one hand, because richer people tend to con-
sume more medical services, the inclusion of the morbidity 
controls  should  attenuate  the  effect  of  income,  holding 
all other factors equal. On the other hand, poorer people 
tend to be sicker people who, other factors held constant, 
consume more medical services, thus causing the inclusion 
of morbidity controls to increase the effect of income. The 
existence of these two countervailing effects suggests that 
the inclusion of the morbidity controls would have no net 
impact on the estimated effect of income.
Belonging to an HMO increased the probability of mam-
mography  screening  in  our  study.  Differing  pecuniary 
incentives  do  not  explain  this  finding  because  there  is 
no cost to the individual for mammography in either the 
preferred provider organization (PPO) plan or the HMO 
plan. However, HMO members of the health care plan in 
this study are required to choose a principal provider for 
their care and, as part of the health plan’s quality care 
initiative, principal providers receive lists of patients who 
do  not  receive  mammograms.  This  practice  is  not  part 
of the PPO plan, a difference that is consistent with the 
commonly held notion that HMOs tend to place a greater 
emphasis on preventive care than do PPOs. Nevertheless, 
other studies do not find any relationship between mam-
mography and HMO participation (11).  
Finally,  our  suggestion  that  race  data  are  not  miss-
ing randomly (Table 2, column 6) provides an important 
caveat to researchers who wish to use voluntary question-
naires to make inferences about population relationships.
So, if income gradients in mammography use are not 
caused by lack of coverage or geographic isolation, then 
what is responsible for them? We explore some possible 
explanations below.
Mechanisms 
Ex ante moral hazard 
One  possible  explanation  for  our  findings  is  ex  ante 
moral hazard, or the notion that insurance coverage for 
curative care reduces the incentive for investing in preven-
tive care (23,24). The issue of ex ante moral hazard does 
not explain our results for several reasons. First, for ex 
ante moral hazard to be responsible for our results, cover-
age of curative care would have to differ systematically 
between rich and poor members, which it does not. Second, 
although insurance at least partially mitigates the costs 
of cancer treatment, risks such as increased probability of 
death due to late detection remain even with comprehen-
sive insurance coverage. Given this information, it is not 
surprising that evidence of ex ante moral hazard is scant 
in the literature (23).
Time costs 
Another  possible  explanation  for  our  results  is  that 
poorer  people  incur  a  higher  time  cost  for  obtaining  a 
mammogram. For example, richer people may have more 
flexible employment, enabling them to take time off work 
with little or no effect on their earnings. Poorer people 
may also tend to have wage-based rather than salaried 
jobs, meaning that they must forgo valuable work time to 
see a physician or obtain a mammogram. Moreover, poorer 
people  may  rely  more  heavily  on  public  transportation 
than do richer people, which would also tend to increase 
the time cost of obtaining medical care. Indeed, evidence 
exists that these time costs may be particularly important 
among Asian Americans (25), of whom there are many in 
Hawaii. Thus, time costs may be an important mechanism 
in this study.
Information 
A third possible explanation for our results is that poorer 
members are less informed than richer members about the 
potential benefits of mammography screening. Although 
the  benefits  of  early  detection  are  well-documented  in 
the literature, this information may not be disseminated 
equally  across  the  earnings  distribution.  Indeed,  some 
evidence  suggests  that  race,  which  is  highly  correlated 
with income, is a significant predictor of attitudes toward 
the  efficacy  of  screening  for  breast  and  cervical  cancer 
(26,27).
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Limitations and further work 
Our study has several limitations. First, data are from 
a single health plan in Hawaii and may not generalize to 
other settings or populations. Second, we had race infor-
mation available only on a subset of members who had 
seen their doctor in the past year. Racial disparities in 
breast cancer screening for the general population may 
differ from our results. Third, information on relevant fac-
tors such as health beliefs, transportation, and family his-
tory of disease was not available. Fourth, we used median 
income level by census tract rather than an individual’s 
actual income, which introduces measurement error.
Despite  these  limitations,  our  findings  suggest  that 
an income gradient exists in the probability of obtaining 
breast  cancer  screening,  with  low-income  women  being 
less likely than high-income women to receive screenings. 
To address this disparity, further research will be needed 
to identify the reasons for lack of compliance with recom-
mended guidelines. For instance, we could use chart data 
to  determine  how  often  physicians  schedule  screenings 
that patients fail to attend. Analyzing barriers to breast 
cancer screenings from the patient perspective is also of 
interest.
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Tables
Table 1. Sample (N = 46,328) Characteristics, Study on 
Socioeconomic Disparities in Breast Cancer Screening in 
Hawaii, 2003–2004
Characteristic Value
Age, y, mean (SD) 58.4 (5.4)
Health plan type, % of individuals
Health maintenance organization 20
Preferred provider organization 80
Morbidity level, % of individualsa
0 2.
0.5 2.7
 6.
.5 9.0
2 4.
2.5 7.6
 2.
.5 0.7
4 8.
4.5 4.
5 .7
Median annual income in member’s census tract, mean (SD), 
2000 dollarsb
Per family income 65,024 (9,4)
Per capita family income 24,2 (7,884)
Race reported, % of individualsc 8
Chinese 7
Japanese 40
Filipino 9
Korean 2
Hawaiian 
White 8
Mixed race 8
Other race 4
Race not reported, % of individuals 62
 
a We used a morbidity index from the Adjusted Clinical Group case-mix 
adjustment system, which categorizes a patient’s clinical conditions into 
one of six integer categories ranging from zero through five (2). Higher 
numbers indicate worse morbidity. We used the median value of the index 
for 200 and 2004. 
b Sample size is 46,20. 
c These values correspond only to the subsample of members who 
responded to the member satisfaction questionnaire.
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Table 2. Probit Models in Which the Dependent Variable is an Indicator for Having Had a Mammogram, Study on 
Socioeconomic Disparities in Breast Cancer Screening in Hawaii, 2003–2004a 
Category
Variables
Per Capita Family Income Family Income Morbidity Level Region
Race and 
Member 
of Health 
Maintenance 
Organization 
(HMO)
No Additional 
Controls Dummy Variables for Age
Dummy Variables for Age
Actual 
Morbidity Index
Dummy 
Variables for 
Morbidity 
Category
Dummy Variables for Morbidity 
Levels
Dummy 
Variables 
for Member 
Location
Dummy Variable 
for Member 
Location
Dummy 
Variables 
for Race and for 
HMO Member 
or Not
Column no.  2  4 5 6 7
No. in sample 46,28 46,20 46,20 46,28 46,28 46,28 46,28
Income
Log per capita 
family income
0.098 (7.0) 0.098 (7.27) — 0.099 (7.) 0.098 (7.8) 0.26 (0.06) 0.0 (9.72)
Log family income — — 0.076 (6.09) — — — —
Age, y
Ages 50 to 54 — −0.017 (−2.21) −0.021 (−3.33) 0.026 (.6) 0.06 (2.00) 0.04 (.76) 0.02 (2.67)
Ages 55 to 59 — −0.003 (−0.41) −0.007 (−1.10) 0.026 (.58) 0.08 (2.48) 0.07 (2.9) 0.022 (.07)
Ages 60 to 64 — 0.005 (0.8) −0.005 (−0.73) 0.08 (2.42) 0.0 (.46) 0.00 (.9) 0.04 (.79)
Member of HMO — — — — — — 0.06 (2.67)
Race
Chinese — — — — — — 0.082 (.46)
Filipino — — — — — — −0.015 (−0.60)
Japanese — — — — — — 0.060 (2.9)
Korean — — — — — — 0.058 (.66)
Hawaiian — — — — — — −0.014 (−0.61)
White — — — — — — 0.00 (.7)
Mixed race — — — — — — 0.002 (0.0)
Race data miss-
ing
— — — — — — −0.063 (−3.17)
Morbidity level — — — 0.086 (8.64) — — —
Pseudo R-
squared
0.00 0.00 0.0020 0.027 0.0569 0.0609 0.0688
 
Dashes (—) indicate that data do not apply.  
a The top number in each cell, unless otherwise indicated, is the marginal impact of the corresponding variable and the bottom number, in parentheses, is 
the t statistic corresponding to the underlying coefficient. All standard errors adjust for clustering within census tracts.  
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2004a 
Region
Marginal Effect of Log per Capita Family Income
Marginal Impact of 
Income t Statistic Sample Size
East Hawaii 0.8 .60 2,95
Maui 0.07 .4 ,06
Honolulu 0.2 (6.5) 9,7
Oahu (other than Honolulu) 0.5 (9.40) 8,752
 
a This table contains the results of probit models in which the dependent variable is an indicator for having had a mammogram within the past 2 years. Each 
regression contains age and morbidity dummies. All standard errors adjust for clustering within census tracts.
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